Industry News

2003 Legislation to Slow Spiraling Drug Costs – Epic Fail For Oncology Drugs

Three Keys to Developing a Medical Affairs Launch Readiness Plan in Europe

Another NICE Recommendation For Bayer’s Xarelto

How Much Higher Are Medical Costs With Hospital-Owned Physician Groups?

Check Out The Latest ISPOR Value in Health Regional Issue

Survey Results On Data Requirements and Availablility in the EU

Clinical Data & Economic Impact Both Hot Topics In Upcoming Meeting On Liver Diseases

What’s New With The Georgetown Navigator Technical Assistance Project?

Blame-Shifting Continues With PhRMA’s New Website

Cancer Drug Pricing By Indication Worth Pursuing?

It’s Do Or Die – Can American Health Insurance Companies Make The Change?

Could England See A 25% Cut In Pharmaceutical Pricing?

Improving Patient Experience With Data Analytics

Top 10 Emerging Health Care Trends Report Finds Opportunities to Achieve Triple Aim of Health Reform

Specialty Pharmacy Trends Report: Focus On Rheumatoid Arthritis

Covance Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award

ISPOR Members – Don’t Miss This FREE Educational Webinar!

Analytics – It’s The Journey Not The Destination That Matters

HealthEconomics.Com’s Top Five Stories Of The Week!

Ulcerative Colitis Drug Trio Receives Negative Draft Guidance

A Step-By-Step Guide To Phama Market Access In Germany

How Do You Decide Which Evidence To Include In Your Presentations?

ISPOR Is Looking For Nominations For Board Of Directors

Did You Catch This Podcast With Relentless Health And Patti Peeples On The History Of Health Economics?

What If You Only Had To Pay For A Medication If It Worked?

A New Market Access Modus Operandi For US Pharma – Are You Ready?

Is The QALY A Valid Measurement?

Don’t Miss The Nation’s Largest Specialty Pharmacy Conference – Register Today!

A Quick Recap Of ISPOR’s HTA Asian Roundtable

If We Could Look Into The Future – What Would Healthcare Look Like?


Stay Connected